Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

NCT01022749 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease (IBD)

Interventions

DRUG: Vaccine
BIOLOGICAL: Vaccine anti-H1N1

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]